Hjem › Alzheimers sykdom › Colorado
Kliniske studier for Alzheimers sykdom i Colorado
13 studier for Alzheimers sykdom søker deltakere på steder i Colorado.
Byer i Colorado
Offisiell studietekst (engelsk)
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
- Clinical Site, Denver
RekruttererFase 2
Alder 55 til 90 · Alle kjønn · Oppdatert 30. sep. 2026 · NCT06887192A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
- CenExel Rocky Mountain Clinical Research, Englewood
RekruttererFase 2
Alder 55 til 85 · Alle kjønn · Oppdatert 22. sep. 2026 · NCT07589595Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease
- CenExel Denver, CO, Englewood
RekruttererFase 2
Alder 55 til 80 · Alle kjønn · Oppdatert 21. sep. 2026 · NCT06847321A Study to Assess the Safety and Effects of ABBV-1758 Following Subcutaneous or Intravenous Injections in Participants With Alzheimer's Disease
- Alpine Clinical Research Center - Boulder - 47th Street /ID# 277856, Boulder
RekruttererFase 1/2
Alder 50 til 90 · Alle kjønn · Oppdatert 18. sep. 2026 · NCT07599670A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)
- Research of the Rockies, Colorado Springs
RekruttererFase 3
Alder 60 til 85 · Alle kjønn · Oppdatert 17. sep. 2026 · NCT06976203Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
- University of Colorado Anschutz Medical Campus, Aurora
RekruttererFase 2
Alder 55 til 90 · Alle kjønn · Oppdatert 1. sep. 2026 · NCT06808984A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
- Mountain Neurological Research Center, Basalt
RekruttererFase 3
Alder 60 til 85 · Alle kjønn · Oppdatert 20. aug. 2026 · NCT06976216Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
- University of Colorado Anschutz, Aurora
RekruttererFase 3
Alder 18 til 75 · Alle kjønn · Oppdatert 4. aug. 2026 · NCT06563895CBD for Individuals at Risk for Alzheimer's Disease
- University of Colorado - Anschutz Medical Campus, Aurora
RekruttererFase 2
Alder 55 til 85 · Alle kjønn · Oppdatert 15. jun. 2026 · NCT05822362Trial-Ready Cohort-Down Syndrome (TRC-DS)
- Linda Crnic Institute for Down Syndrome, University of Colorado, Aurora
RekruttererObservasjonsstudie
Alder 25 til 55 · Alle kjønn · Oppdatert 18. mai 2026 · NCT04165109Phase II Trial to Evaluate Safety and Efficacy of GM-CSF/Sargramostim in Alzheimer's Disease
- University of Colorado Anschutz Medical Campus, Aurora
RekruttererFase 2
Alder 60 til 85 · Alle kjønn · Oppdatert 30. apr. 2026 · NCT04902703Intervention to Collect and Utilize Sexual Orientation and Gender Identity (SOGI) Information in Hospice
- University of Colorado, Aurora
RekruttererFrivillige helsepersonell ønskes velkommen
Alder 18 og eldre · Alle kjønn · Oppdatert 24. jun. 2024 · NCT05877391Enhancing Sleep Quality for Nursing Home Residents With Dementia - R33 Phase
- Vivage/Beecan Corporation, Lakewood
Rekrutterer
Alder 50 og eldre · Alle kjønn · Oppdatert 12. mar. 2024 · NCT05820919Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.